Company research
NIKA PHARMACEUTICALS, INC
CIK 1145604Updated Nov 11, 2026
SecurityNIKA · OTC · equity
Historical securities (1)
NIKA · OTC · equity · closed May 3, 2024Name history
CENTENNIAL GROWTH EQUITIES INC · through Aug 15, 2022
NIKA price & chart
Loading TradingView…
OTC:NIKA on TradingView ↗In the news
Nika Pharmaceuticals, Inc. (OTCQB: NIKA) June 2026 Update ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 23,625Source | 1,386Source | 9,942Source | 31,607Source | 390,323Source | 20,637Source | 34,988Source | 41,473Source | 20,996Source | 17,934Source | 19,596Source | 864Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 6,287Source | 1,386Source | 2,932Source | 15,616Source | 7,486Source | 1,530Source | 19,137Source | 24,466Source | 1,889Source | 2,083Source | 19,596Source | 864Source |
| Assets, CurrentUSD | 23,625Source | 1,386Source | 9,942Source | 31,607Source | 222,063Source | 20,637Source | 34,988Source | 41,473Source | 20,996Source | 17,934Source | 19,596Source | 864Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 284,164Source | 210,164Source | 340,624Source | 284,164Source | 636,934Source | 331,624Source | 269,164Source | 265,955Source | 318,624Source | 239,164Source | 101,745Source | 18,180Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 1,500Source | 1,500Source | 1,500Source | 1,500Source | 1,500Source | 1,500Source | 1,500Source | 1,000Source | 1,500Source | 1,500Source | 1,000Source | 10,000Source |
| Common Stock, Value, IssuedUSD | 103,964Source | 101,852Source | 105,170Source | 102,641Source | 101,852Source | 104,856Source | 102,637Source | 87,609Source | 104,756Source | 102,168Source | 87,609Source | 87,609Source |
| Additional Paid in CapitalUSD | 8,600,917Source | 8,603,030Source | 8,599,711Source | 8,602,240Source | 8,606,040Source | 8,600,026Source | 8,602,244Source | 8,617,773Source | 8,600,125Source | 8,602,714Source | 3,229,489Source | 3,220,489Source |
| Retained Earnings (Accumulated Deficit)USD | -8,966,920Source | -8,915,160Source | -9,037,063Source | -8,958,938Source | -8,956,004Source | -9,017,369Source | -8,940,557Source | -8,930,864Source | -9,004,009Source | -8,927,612Source | -3,400,247Source | 3,335,414Source |
| Stockholders' Equity Attributable to ParentUSD | -260,539Source | -200,411Source | -330,682Source | -252,557Source | -298,824Source | -310,987Source | -234,176Source | -224,482Source | -297,628Source | -221,230Source | -82,149Source | -17,316Source |
| Liabilities and EquityUSD | 23,625Source | 1,386Source | 9,942Source | 31,607Source | 390,323Source | 20,637Source | 34,988Source | 41,473Source | 20,996Source | 17,934Source | 19,596Source | 864Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 284,164Source | 210,164Source | 340,624Source | 284,164Source | 636,934Source | 331,624Source | 269,164Source | 265,955Source | 318,624Source | 239,164Source | 101,745Source | 18,180Source |
| Property, Plant and Equipment, Net | — | — | — | — | —Source | — | — | — | — | — | — | — |
| Accounts Receivable, after Allowance for Credit Loss, Current | — | — | — | — | —Source | — | — | — | — | — | — | — |
| Inventory, Net | — | — | — | — | —Source | — | — | —Source | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | -7,982Source | -8,367Source | -19,694Source | -18,381Source | — | -12,945Source | -76,398Source | -95,792Source | -64,833Source | 3,183,715Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -13,359Source | -12,945Source | -79,654Source | -139,081Source | 64,833Source | 33,715Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 13,000Source | 30,000Source | 79,460Source | 137,419Source | 83,565Source | 34,180Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -359Source | -17,055Source | -194Source | -17,513Source | 18,732Source | 465Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 6,287Source | 1,386Source | 2,932Source | 15,616Source | 1,530Source | 19,137Source | 1,889Source | 2,083Source | 19,596Source | — |
| Additional Financial Items | ||||||||||||
| General and Administrative ExpenseUSD | — | — | 3,901Source | 6,302Source | 14,848Source | 14,300Source | 2,639Source | 1,800Source | 53,026Source | 35,174Source | 64,833Source | 33,715Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -7,999Source | -8,367Source | -19,694Source | -18,381Source | -13,359Source | -12,945Source | -76,398Source | -95,792Source | -64,833Source | -3,183,715Source |
| Noncash Merger Related CostsUSD | — | — | — | — | — | — | — | — | — | 43,289Source | — | — |
| Operating ExpensesUSD | — | — | 7,982Source | 8,367Source | 19,694Source | 18,381Source | 13,359Source | 12,945Source | 76,398Source | 95,792Source | 64,833Source | 3,183,715Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | — | — | — | 10,000Source |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source |
| Operating Income (Loss)USD | — | — | -7,999Source | -8,367Source | -19,694Source | -18,381Source | -13,359Source | -12,945Source | -76,398Source | -95,792Source | -64,833Source | -3,183,715Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -7,999Source | -8,367Source | -19,694Source | -18,381Source | -13,359Source | -12,945Source | -76,398Source | -95,792Source | -64,833Source | -3,183,715Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -7,999Source | -8,367Source | -19,694Source | -18,381Source | -13,359Source | -12,945Source | -76,398Source | -95,792Source | -64,833Source | -3,183,715Source |
| Earnings Per Share, BasicUSD per share | — | — | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Earnings Per Share, DilutedUSD per share | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | — | 0Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | — | — | 1,051,689,224Source | 1,026,406,001Source | 1,048,549,224Source | 1,026,371,000Source | 1,047,549,224Source | 1,021,674,500Source | 876,090,000Source | 723,953,014Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 1,039,836,001Source | 1,018,519,500Source | 1,051,689,224Source | 1,026,406,001Source | 1,048,549,224Source | 1,026,371,000Source | 1,047,549,224Source | 1,021,674,500Source | — | 723,953,014Source |
| Additional Financial Items | ||||||||||||
| Business Combination, Acquisition Related CostsUSD | — | — | — | — | — | — | — | — | — | — | — | 150,000Source |
| General and Administrative ExpenseUSD | — | — | 3,901Source | 6,302Source | 14,848Source | 14,300Source | 2,639Source | 1,800Source | 53,026Source | 35,174Source | 64,833Source | 33,715Source |
| Operating ExpensesUSD | — | — | 7,982Source | 8,367Source | 19,694Source | 18,381Source | 13,359Source | 12,945Source | 76,398Source | 95,792Source | 64,833Source | 3,183,715Source |